Literature DB >> 3138434

Vaccinia virus recombinants expressing an 11-kilodalton beta-galactosidase fusion protein incorporate active beta-galactosidase in virus particles.

C Huang1, W A Samsonoff, A Grzelecki.   

Abstract

Recombinant plasmids in which vaccinia virus transcriptional regulatory sequences were fused to the Escherichia coli lacZ gene were constructed for insertion of the lacZ gene into the vaccinia virus genome. beta-Galactosidase (beta-gal) was found in some purified recombinant vaccinia virions. By enzyme activity, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and microscopic techniques, the evidence suggested that beta-gal accounted for 5% of the total protein in the virion. These recombinant viruses were constructed so that a portion of the coding sequences of a late vaccinia virus structural polypeptide was fused to the amino terminus of beta-gal to produce the fusion protein. Removal of the coding sequences resulted in the complete loss of beta-gal activity. This demonstrated that a vaccinia virus DNA segment from a late structural gene is responsible for the incorporation of beta-gal into the virion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3138434      PMCID: PMC253532     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  Live recombinant vaccines using genetically engineered vaccinia virus.

Authors:  E Paoletti; M E Perkus; A Piccini
Journal:  Antiviral Res       Date:  1985       Impact factor: 5.970

2.  Plasmodium knowlesi sporozoite antigen: expression by infectious recombinant vaccinia virus.

Authors:  G L Smith; G N Godson; V Nussenzweig; R S Nussenzweig; J Barnwell; B Moss
Journal:  Science       Date:  1984-04-27       Impact factor: 47.728

3.  Mapping of a gene coding for a major late structural polypeptide on the vaccinia virus genome.

Authors:  R Wittek; M Hänggi; G Hiller
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

4.  Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle.

Authors:  M Mackett; T Yilma; J K Rose; B Moss
Journal:  Science       Date:  1985-01-25       Impact factor: 47.728

5.  Vaccinia virus vectors utilizing the beta-galactosidase assay for rapid selection of recombinant viruses and measurement of gene expression.

Authors:  D Panicali; A Grzelecki; C Huang
Journal:  Gene       Date:  1986       Impact factor: 3.688

6.  General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

Authors:  M Mackett; G L Smith; B Moss
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

7.  Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters.

Authors:  G L Smith; B R Murphy; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

8.  Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene.

Authors:  T J Wiktor; R I Macfarlan; K J Reagan; B Dietzschold; P J Curtis; W H Wunner; M P Kieny; R Lathe; J P Lecocq; M Mackett
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

9.  Live recombinant vaccinia virus protects chimpanzees against hepatitis B.

Authors:  B Moss; G L Smith; J L Gerin; R H Purcell
Journal:  Nature       Date:  1984 Sep 6-11       Impact factor: 49.962

10.  Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.

Authors:  S Chakrabarti; K Brechling; B Moss
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

View more
  2 in total

Review 1.  Vaccinia virus vectors: new strategies for producing recombinant vaccines.

Authors:  D E Hruby
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

2.  The live vector approach-viruses.

Authors:  M Mackett
Journal:  World J Microbiol Biotechnol       Date:  1991-03       Impact factor: 3.312

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.